These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8369577)

  • 41. The correlation between response to oral cyclosporin therapy and systemic inflammation, metabolic abnormality in patients with psoriasis.
    Ohtsuka T
    Arch Dermatol Res; 2008 Nov; 300(10):545-50. PubMed ID: 18797895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic cyclosporine treatment in severe childhood psoriasis: A retrospective chart review.
    Dogra S; Mahajan R; Narang T; Handa S
    J Dermatolog Treat; 2017 Feb; 28(1):18-20. PubMed ID: 27771982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intermittent vs. continuous 1-year cyclosporin use in chronic plaque psoriasis.
    Chaidemenos GC; Mourellou O; Avgoustinaki N; Papakonstantinou M; Karakatsanis G; Katsambas A
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1203-8. PubMed ID: 17894706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Etanercept reduces symptoms and severity of psoriasis after cessation of cyclosporine therapy: results of the SCORE study.
    Micali G; Wilsmann-Theis D; Mallbris L; Gallo G; Marino V; Brault Y; Germain JM
    Acta Derm Venereol; 2015 Jan; 95(1):57-61. PubMed ID: 24682319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.
    Ho VC; Griffiths CE; Berth-Jones J; Papp KA; Vanaclocha F; Dauden E; Beard A; Puvanarajan L; Paul C
    J Am Acad Dermatol; 2001 Apr; 44(4):643-51. PubMed ID: 11260540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful Secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis.
    Mugheddu C; Atzori L; Lappi A; Pau M; Murgia S; Rongioletti F
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e420-e421. PubMed ID: 28319281
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical and immunohistochemical assessment of the effect of cyclosporin in keratinocytes and dermal dendrocytes in psoriasis.
    Lago E; Carneiro S; Cuzzi T; Magalhães G; Cássia F; Pessanha F; Ramos-e-Silva M
    J Cutan Pathol; 2007 Jan; 34(1):15-21. PubMed ID: 17214849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgaris.
    Hashizume H; Ito T; Yagi H; Takigawa M; Kageyama H; Furukawa F; Hata M; Shirahama S; Tanaka M; Higashishiba T; Machida H; Tsushima T; Matsushita K
    J Dermatol; 2007 Jul; 34(7):430-4. PubMed ID: 17584318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative non randomized study of narrow-band (NB) (312 +/- 2 nm) UVB phototherapy versus sequential therapy with oral administration of low-dose Cyclosporin A and NB-UVB phototherapy in patients with severe psoriasis vulgaris.
    Calzavara-Pinton P; Leone G; Venturini M; Sala R; Colombo D; La Parola IL; Sitzia N; Ferraro C; Picardo M
    Eur J Dermatol; 2005; 15(6):470-3. PubMed ID: 16280301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-dose cyclosporin improves the health-related quality of life in Japanese psoriasis patients dissatisfied with topical corticosteroid monotherapy.
    Hashimoto T; Kawakami T; Tsuruta D; Hamada T; Natsuaki Y; Fukuda S; Koga H; Sogame R; Ohyama B; Ono F; Karashima T; Nakama T; Dainichi T; Ishii N; Yasumoto S
    Australas J Dermatol; 2012 Aug; 53(3):202-6. PubMed ID: 22881466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erythrodermic psoriasis. Report of a case associated with symptomatic hypophosphataemia.
    McElhenny BE; Todd DJ; McCance D; Young I; Burrows D
    Clin Exp Dermatol; 1993 Mar; 18(2):167-8. PubMed ID: 8481998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of recalcitrant erythrodermic psoriasis with ustekinumab.
    Stinco G; Piccirillo A; Errichetti E; Bergamo S; Patrone P
    Eur J Dermatol; 2014; 24(3):387-90. PubMed ID: 24721883
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of short-course class 1 topical glucocorticoid under occlusion for the rapid control of erythrodermic psoriasis.
    Arbiser JL; Grossman K; Kaye E; Arndt KA
    Arch Dermatol; 1994 Jun; 130(6):704-6. PubMed ID: 8002640
    [No Abstract]   [Full Text] [Related]  

  • 54. Long-term remission induced by secukinumab in a 13-year-old boy having recalcitrant chronic erythrodermic psoriasis.
    Dogra S; Bishnoi A; Narang T; Handa S
    Dermatol Ther; 2018 Jul; 31(4):e12611. PubMed ID: 29687662
    [No Abstract]   [Full Text] [Related]  

  • 55. Approaches to discontinuing efalizumab: an open-label study of therapies for managing inflammatory recurrence.
    Papp KA; Toth D; Rosoph L
    BMC Dermatol; 2006 Oct; 6():9. PubMed ID: 17067371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood concentrations and clinical effect of cyclosporin in psoriasis.
    Furlanut M; Baraldo M; Pea F; Marzocchi V; Croattino L; Galla F
    Ther Drug Monit; 1996 Oct; 18(5):544-8. PubMed ID: 8885117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.
    Ojeda R; Sánchez Regaña M; Massana J; Oliete R; Umbert P
    J Dermatolog Treat; 2005; 16(4):238-41. PubMed ID: 16249146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of biologics in erythrodermic psoriasis: a multicentre, retrospective study.
    Viguier M; Pagès C; Aubin F; Delaporte E; Descamps V; Lok C; Beylot-Barry M; Séneschal J; Dubertret L; Morand JJ; Dréno B; Bachelez H;
    Br J Dermatol; 2012 Aug; 167(2):417-23. PubMed ID: 22413927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclosporin in psoriasis: continuous monotherapy versus intermittent long-term therapy.
    Ozawa A; Sugai J; Ohkido M; Ohtsuki M; Nakagawa H; Kitahara H; Tamaki K; Urabe K; Nakayama J; Horikoshi T; Morimoto Y; Jimbow K
    Eur J Dermatol; 1999; 9(3):218-23. PubMed ID: 10210789
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erythrodermic psoriasis. Precipitating factors, course, and prognosis in 50 patients.
    Boyd AS; Menter A
    J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):985-91. PubMed ID: 2530253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.